Latest News

14 Dec 2015 FDA Approves Alectinib for the Treatment of Advanced ALK-positive NSCLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
10 Dec 2015 New Treatments in Melanoma
10 Dec 2015 Limited offer: Free submission for ESMO Open
10 Dec 2015 FDA Allows Marketing of Cooling Cap to Reduce Alopecia During Chemotherapy Palliative and supportive care
09 Dec 2015 Midostaurin Prolongs Survival in Newly Diagnosed Acute Myeloid Leukaemia Patients With FLT3 Mutations Haematologic malignancies - Anticancer agents & Biologic therapy
07 Dec 2015 PD-1 Blockade Sets a New Benchmark in Previously Treated Metastatic Renal Cell Carcinoma (mRCC) Genitourinary cancers
General Assembly
03 Dec 2015 FDA Approves Elotuzumab for the Treatment of Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Dec 2015 Lung Adenocarcinoma With HER2 Mutations Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
01 Dec 2015 Latest Lung Cancer E-Learning Now Online!
01 Dec 2015 NHS England and NICE Have Begun a Consultation on a New Cancer Drugs Fund Bioethics, legal and economic issues
30 Nov 2015 FDA Approves Nivolumab as a Single Agent for Previously Untreated BRAF Wild-Type Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
27 Nov 2015 FDA Approves Necitumumab to Treat Advanced Squamous NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy